Last reviewed · How we verify

NCT05382975: CSPAP-T

A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T)

Recruiting now NA Last updated 26 June 2024
What this trial tests

NA trial testing CSPAP-T in Physical Activity in 8,000 participants. Currently enrolling.

Timeline
1 August 2022
Primary endpoint
1 July 2026
31 December 2026

Quick facts

Lead sponsorSeattle Children's Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment8,000
Start date1 August 2022
Primary completion1 July 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Seattle Children's Hospital

Who can join

11 and older, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will conduct a hybrid implementation-effectiveness trial of a trauma-adapted Comprehensive School Physical Activity Program (CSPAP) intervention. A clustered stepped wedge design will be used, with the duration of the trial being 3 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Strategies for enhancing the implementation of school-based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use.
    Lee DC, O'Brien KM, McCrabb S, Wolfenden L, et al · · 2024 · cited 11× · PMID 39665378 · DOI 10.1002/14651858.cd011677.pub4

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Seattle Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05382975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing